Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis

被引:78
作者
Ahmad, A
Alvarez, F
机构
[1] Univ Montreal, Hop St Justine, Res Ctr, Lab Immunovirol, Montreal, PQ H3T 1C5, Canada
[2] Univ Montreal, Hop St Justine, Dept Microbiol & Immunol, Montreal, PQ H3T 1C5, Canada
[3] Univ Montreal, Hop St Justine, Dept Pediat, Montreal, PQ H3T 1C5, Canada
关键词
hepatitis C virus; natural killer cells; NK cell receptors; NK cell co-receptors;
D O I
10.1189/jlb.0304197
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Natural killer (NK) cells constitute the first line of host defense against invading pathogens. They usually become activated in an early phase of a viral infection. Liver is particularly enriched in NK cells, which are activated by hepatotropic viruses such as hepatitis C virus (HCV). The activated NK cells play an essential role in recruiting virus-specific T cells and in inducing antiviral immunity in liver. They also eliminate virus-infected hepatocytes directly by cytolytic mechanisms and indirectly by secreting cytokines, which induce an antiviral state in host cells. Therefore, optimally activated NK cells are important in limiting viral replication in this organ. This notion is supported by the observations that interferon treatment is effective in HCV-infected persons in whom it increases NK cell activity. Not surprisingly, HCV has evolved multiple strategies to counter host's NK cell response. Compromised NK cell functions have been reported in chronic HCV-infected individuals. It is ironic that activated NK cells may also contribute toward liver injury. Further studies are needed to understand the role of these cells in host defense and in liver pathology in HCV infections. Recent advances in understanding NK cell biology have opened new avenues for boosting innate and adaptive antiviral immune responses in HCV-infected individuals.
引用
收藏
页码:743 / 759
页数:17
相关论文
共 180 条
  • [71] Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1 VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas
    Ivanovski, M
    Silvestri, F
    Pozzato, G
    Anand, S
    Mazzaro, C
    Burrone, OR
    Efremov, DG
    [J]. BLOOD, 1998, 91 (07) : 2433 - 2442
  • [72] Jewett A, 1997, J IMMUNOL, V158, P5492
  • [73] Jewett A, 1996, J IMMUNOL, V156, P907
  • [74] Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid
    Jinushi, M
    Takehara, T
    Tatsumi, T
    Kanto, T
    Groh, V
    Spies, T
    Kimura, R
    Miyagi, T
    Mochizuki, K
    Sasaki, Y
    Hayashi, N
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2003, 104 (03) : 354 - 361
  • [75] Critical role of MHC class I-related chain A and B expression on IFN-α-stimulated dendritic cells in NK cell activation:: Impairment in chronic hepatitis C virus infection
    Jinushi, M
    Takehara, T
    Kanto, T
    Tatsumi, T
    Groh, V
    Spies, T
    Miyagi, T
    Suzuki, T
    Sasaki, Y
    Hayashi, N
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 170 (03) : 1249 - 1256
  • [76] Cutting edge: Inhibition of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver
    Kakimi, K
    Lane, TE
    Chisari, FV
    Guidotti, LG
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (12) : 6701 - 6705
  • [77] Natural killer T cell activation inhibits hepatitis B virus replication in vivo
    Kakimi, K
    Guidotti, LG
    Koezuka, Y
    Chisari, FV
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (07) : 921 - 930
  • [78] Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition
    Kammer, AR
    van der Burg, SH
    Grabscheid, B
    Hunziker, IP
    Kwappenberg, KMC
    Reichen, J
    Melief, CJM
    Cerny, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (02) : 169 - 176
  • [79] EXPRESS YOURSELF OR DIE - PEPTIDES, MHC MOLECULES, AND NK CELLS
    KARRE, K
    [J]. SCIENCE, 1995, 267 (5200) : 978 - 979
  • [80] SELECTIVE REJECTION OF H-2-DEFICIENT LYMPHOMA VARIANTS SUGGESTS ALTERNATIVE IMMUNE DEFENSE STRATEGY
    KARRE, K
    LJUNGGREN, HG
    PIONTEK, G
    KIESSLING, R
    [J]. NATURE, 1986, 319 (6055) : 675 - 678